Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
IR-Med, Inc. develops non-invasive point-of-care diagnostic devices utilizing infrared spectroscopy and AI to assess and monitor conditions like pressure injuries and diabetic foot ulcers. Its products, PressureSafe and DiaSafe, target healthcare providers, hospitals, and homecare markets worldwide. The company's innovative technology aims to improve early diagnosis, reduce healthcare costs, and address unmet medical needs through portable, AI-driven solutions.
This description was generated via AI from an annual report. Updated about 1 year ago.